NCT00224003View on ClinicalTrials.gov

Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

February 28, 2005

Conditions
Anemia
Interventions
DRUG

Sodium Ferric Gluconate Complex in Sucrose.

Trial Locations (10)

Unknown

Birmingham

Los Angeles

San Diego

Stanford

Atlanta

Boston

Kansas City

The Bronx

Dallas

Seattle

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00224003 - Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients | Biotech Hunter | Biotech Hunter